Biogenix Molecular is a clinical research site located in Miami, Florida, United States 33165.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Biogenix Molecular has participated in 9 clinical trials with 3 currently active.
Therapeutic areas: Small Cell Lung Cancer Extensive Stage, Merkel Cell Carcinoma, Neuroendocrine Tumors Unresectable.
Sponsors: Ariceum Therapeutics GmbH, Perspective Therapeutics, Pfizer.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Biogenix Molecular has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Biogenix Molecular has 9 clinical trials on record, with 3 currently active. Their work covers Small Cell Lung Cancer Extensive Stage, Merkel Cell Carcinoma, Neuroendocrine Tumors Unresectable.
Yes — Biogenix Molecular holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.